QuidelOrtho secures FDA de-novo authorisation for Sofia 2 SARS Antigen+ FIA test
The Sofia 2 SARS Antigen+ FIA is a prescription use only lateral flow immunofluorescent assay that can be…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
09 Mar 23
The Sofia 2 SARS Antigen+ FIA is a prescription use only lateral flow immunofluorescent assay that can be…
03 Mar 23
Bigfoot aims to free people from the burdens of living with insulin-requiring diabetes, improve access, and support health…
27 Feb 23
The one-year data from the ADAPT study, which evaluated the safety and efficacy of AHCL therapy, showed that…
24 Feb 23
SoloSmart is a single add-on connected device intended for use with SoloStar and DoubleStar insulin injection pens, to…
21 Feb 23
InsulCheck DOSE is designed to automatically capture dose value dialled, injection event time stamp, temperature, mounting and unmounting…
16 Feb 23
The partnership will combine Lark Health’s diabetes management programme Diabetes Care with Smart Meter’s proprietary cellular-enabled iGlucose glucose…
15 Feb 23
AGC and Insulet entered into a license agreement and partnership in 2016 based on patents and other intellectual…
14 Feb 23
The acquisition includes certain patents of Bigfoot Biomedical associated with pumps that could be utilised for automated insulin…
14 Feb 23
Trial to focus on reduction of hemoglobin A1c for patients diagnosed with type 2 diabetes and obesity
09 Feb 23
By using a small, wearable sensor, Dexcom CGM continuously measures and sends glucose levels to a receiver or…